Haplotype analysis revealed that the combination of the variant alleles for TLR9 rs187084 and rs5743836 were associated with a significant decreased risk of endometrial cancer; TT vs CC: OR 0.11, 95% CI (0.03-0.44), p = 0.002 (see Table 2). Here, TLR9 is linked to endometrial cancer.